Focal laser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Focal laser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept

Published:2021-03 Issue:3 Volume:96 Page:162-166
ISSN:2173-5794
Container-title:Archivos de la Sociedad Española de Oftalmología (English Edition)
language:en
Short-container-title:Archivos de la Sociedad Española de Oftalmología (English Edition)

Author:

Tapia Quijada H.E.,Gómez Perera S.,Rodríguez Talavera I.,Mantolan Sarmiento C.,Rocha Cabrera P.,Díaz de Aguilar Osona M.,Serrano García M.

Publisher

Elsevier BV

Reference10 articles.

1. Idiopathic juxtafoveolar retinal telangiectasis update of classification and follow up study;Gass;Ophtalmology.,1993

2. Idiopiopatic telangiectasis macular;Yannuzzi;Arch Ophthalmol.,2006

3. Role of focal laser ablation in the treatment of type 1 idiopathic juxtafoveolar retinal telangiectasis;Hesham, Elmazar;J Egypt Ophthalmol Soc.,2013

4. Perifoveal exudative vascular anomalous complex;Querques;J Fr Ophtalmol.,2011

5. The expanded spectrum of perifoveal exudative vascular anomalous complex;Sacconi;Am J Ophthalmol.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP